Investigating treatment approaches for HIV-associated Kaposi sarcoma in sub-Saharan Africa.
Official title: Project 2
Funded at Lsu Health Sciences Center · NIH-10908998 · Data updated 2026-11-12
This study is looking at how well different treatments work for people with Kaposi sarcoma related to HIV, especially in sub-Saharan Africa, to help improve care for patients with this type of cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $188,224 |
| NIH project number | 5U54CA277846-02 |
| Project ID | NIH-10908998 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with HIV-associated Kaposi sarcoma, particularly those residing in sub-Saharan Africa.
✕Less likely to help
Patients who do not have HIV-associated Kaposi sarcoma or those outside the target geographic region may not benefit from this research.
What this research studies
This research focuses on HIV-associated Kaposi sarcoma (KS), a significant cancer affecting individuals in sub-Saharan Africa. It aims to evaluate the effectiveness of different treatment strategies, including antiretroviral therapy (ART) alone for early-stage disease and ART combined with chemotherapy for more advanced cases. The study will utilize a staging criteria developed by the AIDS Clinical and Trials Group to categorize patients based on tumor extent, immune status, and systemic illness. By understanding the immune response and treatment outcomes, the research seeks to improve care for patients with this malignancy.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment protocols for patients suffering from HIV-associated Kaposi sarcoma.
How similar studies have gone: Previous research has shown promising results in improving treatment outcomes for HIV-associated malignancies, indicating that this approach has potential for success.
Where this research is happening
-
Lsu Health Sciences Center
New Orleans, United States Active
Researchers
- Principal investigator: West, John T. — Lsu Health Sciences Center
- Study coordinator: West, John T.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.